LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 2 of total 2

Search options

  1. Article ; Online: Provider and User Acceptability of Integrated Treatment for the Control of Malaria and Helminths in Saraya, South-Eastern Senegal.

    Afolabi, Muhammed O / Diaw, Aminata / Fall, El Hadji Babacar / Sall, Fatimata Bintou / Diédhiou, Adams / Seck, Amadou / Camara, Baba / Niang, Diatou / Manga, Isaac A / Mbaye, Ibrahima / Sougou, Ndèye Mareme / Sow, Doudou / Greenwood, Brian / Ndiaye, Jean Louis A

    The American journal of tropical medicine and hygiene

    2023  Volume 109, Issue 5, Page(s) 1047–1056

    Abstract: Integration of vertical programs for the control of malaria, schistosomiasis, and soil-transmitted helminthiasis has been recommended to achieve elimination of malaria and neglected tropical diseases (NTD) by 2030. This qualitative study was conducted ... ...

    Abstract Integration of vertical programs for the control of malaria, schistosomiasis, and soil-transmitted helminthiasis has been recommended to achieve elimination of malaria and neglected tropical diseases (NTD) by 2030. This qualitative study was conducted within the context of a randomized controlled trial to explore the perceptions and views of parents/caregivers of at-risk children and healthcare providers to determine their acceptability of the integrated malaria-helminth treatment approach. Randomly selected parents/caregivers of children enrolled in the trial, healthcare providers, trial staff, malaria, and NTD program managers were interviewed using purpose-designed topic guides. Transcripts obtained from the interviews were coded and common themes identified using content analysis were triangulated. Fifty-seven study participants comprising 26 parents/caregivers, 10 study children aged ≥ 10 years, 15 trial staff, four healthcare providers, and two managers from the Senegal Ministry of Health were interviewed. Thirty-eight of the participants (66.7%) were males, and their ages ranged from 10 to 65 years. Overall, the integrated malaria-helminth treatment approach was considered acceptable, but the study participants expressed concerns about the taste, smell, and side effects associated with amodiaquine and praziquantel in the combination package. Reluctance to accept the medications was also observed among children aged 10 to 14 years due to peer influence and gender-sensitive cultural beliefs. Addressing concerns about the taste and smell of amodiaquine and praziquantel is needed to optimize the uptake of the integrated treatment program. Also, culturally appropriate strategies need to be put in place to cater for the inclusion of children aged 10 to 14 years in this approach.
    MeSH term(s) Child ; Male ; Animals ; Humans ; Adolescent ; Young Adult ; Adult ; Middle Aged ; Aged ; Female ; Praziquantel/therapeutic use ; Amodiaquine/therapeutic use ; Senegal/epidemiology ; Helminthiasis/drug therapy ; Helminthiasis/epidemiology ; Helminthiasis/prevention & control ; Helminths ; Malaria/drug therapy ; Malaria/prevention & control
    Chemical Substances Praziquantel (6490C9U457) ; Amodiaquine (220236ED28)
    Language English
    Publishing date 2023-09-18
    Publishing country United States
    Document type Randomized Controlled Trial ; Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2942-7
    ISSN 1476-1645 ; 0002-9637
    ISSN (online) 1476-1645
    ISSN 0002-9637
    DOI 10.4269/ajtmh.23-0113
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Feasibility and safety of integrating mass drug administration for helminth control with seasonal malaria chemoprevention among Senegalese children: a randomized controlled, observer-blind trial.

    Afolabi, Muhammed O / Sow, Doudou / Agbla, Schadrac C / Fall, El Hadji Babacar / Sall, Fatimata Bintou / Seck, Amadou / Manga, Isaac Akhénaton / Mbaye, Ibrahima Marietou / Loum, Mor Absa / Camara, Baba / Niang, Diatou / Gueye, Babacar / Sene, Doudou / Kane, Ndéye M'backé / Diop, Boubacar / Diouf, Awa / Gaye, Ndéye Aida / Diouf, Marie Pierre / Lo, Aminata Colle /
    Greenwood, Brian / Ndiaye, Jean Louis A

    Malaria journal

    2023  Volume 22, Issue 1, Page(s) 348

    Abstract: Background: The overlap in the epidemiology of malaria and helminths has been identified as a potential area to exploit for the development of an integrated control strategy that may help to achieve elimination of malaria and helminths. A randomized, ... ...

    Abstract Background: The overlap in the epidemiology of malaria and helminths has been identified as a potential area to exploit for the development of an integrated control strategy that may help to achieve elimination of malaria and helminths. A randomized, controlled, observer-blind trial was conducted to assess the feasibility and safety of combining mass drug administration (MDA) for schistosomiasis and soil transmitted helminths (STH) with seasonal malaria chemoprevention (SMC) among children living in Senegal.
    Methods: Female and male children aged 1-14 years were randomized 1:1:1, to receive Vitamin A and Zinc on Day 0, followed by SMC drugs (sulfadoxine-pyrimethamine and amodiaquine) on Days 1-3 (control group); or praziquantel and Vitamin A on Day 0, followed by SMC drugs on Days 1-3 (treatment group 1); or albendazole and praziquantel on Day 0, followed by SMC drugs on Days 1-3 (treatment group 2). Safety assessment was performed by collecting adverse events from all children for six subsequent days following administration of the study drugs. Pre- and post-intervention, blood samples were collected for determination of haemoglobin concentration, malaria microscopy, and PCR assays. Stool samples were analyzed using Kato-Katz, Merthiolate-iodine-formalin and PCR methods. Urine filtration, PCR and circulating cathodic antigen tests were also performed.
    Results: From 9 to 22 June 2022, 627 children aged 1-14 years were randomized into the three groups described above. Mild, transient vomiting was observed in 12.6% (26/206) of children in treatment group 2, in 10.6% (22/207) in group 1, and in 4.2% (9/214) in the control group (p = 0.005). Pre-intervention, the geometric mean value of Plasmodium falciparum parasite density was highest among children who received albendazole, praziquantel with SMC drugs. Post-intervention, the parasite density was highest among children who received SMC drugs only. Children who received praziquantel and SMC drugs had a lower risk of developing severe anaemia than their counterparts who received SMC drugs alone (OR = 0.81, 95% CI 0.13-5.00, p = 0.63).
    Conclusions: Integration of MDA for helminths with SMC drugs was safe and feasible among Senegalese children. These findings support further evaluation of the integrated control model.
    Trial registration: The study is registered at Clinical Trial.gov NCT05354258.
    MeSH term(s) Animals ; Humans ; Child ; Male ; Female ; Antimalarials/adverse effects ; Praziquantel/adverse effects ; Albendazole/adverse effects ; Mass Drug Administration ; Seasons ; Feasibility Studies ; Vitamin A/therapeutic use ; Malaria/epidemiology ; Helminths ; Chemoprevention/adverse effects ; Chemoprevention/methods
    Chemical Substances Antimalarials ; Praziquantel (6490C9U457) ; Albendazole (F4216019LN) ; Vitamin A (11103-57-4)
    Language English
    Publishing date 2023-11-13
    Publishing country England
    Document type Randomized Controlled Trial ; Journal Article
    ZDB-ID 2091229-8
    ISSN 1475-2875 ; 1475-2875
    ISSN (online) 1475-2875
    ISSN 1475-2875
    DOI 10.1186/s12936-023-04784-z
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top